Galena Biopharma to Present at the 20th Annual NewsMakers in the Biotech Industry Conference

Galena Biopharma to Present at the 20th Annual NewsMakers in the Biotech
Industry Conference

PORTLAND, Ore., Sept. 23, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma
(Nasdaq:GALE), a biopharmaceutical company developing and commercializing
innovative, targeted oncology treatments that address major unmet medical
needs to advance cancer care, today announced that Mark J. Ahn, Ph.D.,
President and Chief Executive Officer will present a corporate update at the
20^th Annual NewsMakers in the Biotech Industry Conference. The presentation
will take place on Friday, September 27, 2013 at 3:00 p.m. ET at the
Millennium Broadway Hotel in New York, NY.

The presentation will be webcast and available on the Investors section of the
Company's website at www.galenabiopharma.com.

About Galena Biopharma

Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based
biopharmaceutical company developing and commercializing innovative, targeted
oncology treatments that address major unmet medical needs to advance cancer
care. For more information please visit www.galenabiopharma.com.

CONTACT: Remy Bernarda
         Senior Director, Communications
         (503) 405-8258
         rbernarda@galenabiopharma.com

Galena Biopharma, Inc.